1/41
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Bumetanide (loop diuretic)
Bumex
Furosemide (loop diuretic)
Lasix
Chlorothiazide (thiazide diuretic)
Diuril
Nicardipine (dihydropyridine calcium channel blocker)
Cardene
diltiazem (nondihydropyridine calcium channel blocker)
Cardizem
Verapamil - no brand; answer is therapeautic class
Nondihydropyridine calcium channel blocker
enalaprilat (ACE inhibitor)
Vasotec IV
esmolol (beta blocker, beta-1 selective)
Brevibloc
metoprolol (beta blocker, beta-1 selective)
lopressor
propranolol (beta blocker; nonselective)
Inderal
Labetalol (N/A - TC)
beta blocker, non selective and alpha-1 blocker
hydralazine
vasodilator
nitroglycerin
vasodilator
Nitroprusside (vasodilator)
Nipride
milrinone
vasodilator (PDE-3 inhibitor); inotrope
Dobutamine
beta-1 agonist; inotrope
digoxin (antiarrhythmic; inotrope)
lanoxin
amiodarone (antiarrhythmic)
Nexterone
Procainamide
antiarrhythmic class Ia
lidocaine (antiarrhythmic class Ib; local anesthetic)
Xylocaine
adenosine
antiarrhythmic
atropine
anticholinergic; antidote; GI antispasmodic agent
bumetanide
Dose Conversion: furosemide 40 mg = bumetanide 1 mg
furosemide
Furosemide IV:PO ratio 1:2 (furosemide 20mg IV = furosemide 40mg PO
chlorothiazide
Only thiazide available IV
nicardipine
Hypotension (especially with severe aortic stenosis), should not be used in advanced aortic stenosis
diltiazem
Indication(s): Atrial fibrillation/other arrhythmias (rate control)
Warning(s): May worsen symptoms of HF; bradycardia; increased LFTs
Side effect(s): Edema, constipation (more with verapamil than diltiazem), gingival hyperplasia
verapamil CP
Indication(s): Atrial fibrillation/other arrhythmias (rate control)
Warning(s): May worsen symptoms of HF; bradycardia; increased LFTs
Side effect(s): Edema, constipation (more with verapamil than diltiazem), gingival hyperplasia
enalapril
BBW: Fetal toxicity; avoid in pregnancy
Warnings: Angioedema
Side effects: cough, hyperkalemia
Notes: do not use within 36 hours of sacubitril/valsartan
esmolol
Warning(s): Caution in pts with diabetes; can worsen hyperglycemia or hypoglycemia and mask hypoglycemic
conditions. Caution in bronchospastic diseases (asthma and COPD) and Raynaud’s
Note(s): Ultra-short-acting IV beta-1 selective blocker. Effects usually resolve within 10–20 minutes after stopping
the infusion; commonly used for rapid heart rate control and perioperative hypertension/tachycardia
metoprolol
BBW: Do not discontinue abruptly;
Warning(s): Caution in pts with diabetes; can worsen hyperglycemia or hypoglycemia and mask hypoglycemic
conditions. Caution in bronchospastic diseases (asthma and COPD) and Raynaud’s
Note(s): Metoprolol tartrate IV is not equivalent to PO (IV:PO ratio is 1:2.5)
propranolol
BBW: Do not discontinue abruptly
Contraindication(s): Asthma
Warning(s): Caution in pts with diabetes; can worsen hyperglycemia or hypoglycemia and mask hypoglycemic
conditions. Caution in Raynaud’s.
Note(s): High lipid solubility, crosses BBB, associated with more CNS side effects, but makes it useful for other
conditions (migraine prophylaxis). Non-selective BBs are used in portal HTN
labetalol
BBW: Do not discontinue abruptly
Contraindication(s): Asthma
Warning(s): Caution in pts with diabetes; can worsen hyperglycemia or hypoglycemia and mask hypoglycemic
conditions. Caution in Raynaud’s.
Commonly used IV agent for severe hypertension in pregnancy
hydralazine CP
Indication(s): Chronic hypertension, hypertensive emergency (off-label), HFrEF (off-label)
Warning(s): Drug-induced lupus erythematosus (DILE - dose and duration related)
Nitroglycerin
BBW: metabolism produces cyanide
Warnings: Increased intracranial pressure
Notes: Requires light protection during administration
Dobutamine - CP
may turn slightly pink due to oxidation but potency is not lost
Digoxin
Notes: Narrow therapeutic index (monitor digoxin level);
Toxicity: s/sx blurred/double vision, greenish-yellow halos signs of toxicity
Antidote: DigiFab
Amiodarone
BBW: Pulmonary toxicity, hepatotoxicity; proarrhythmic effects. Amiodarone is used for life-threatening
arrhythmias only.
Note(s): Infusions >2 hours require a non-PVC container. Use 0.22 micron filter. Antiarrhythmic drug of choice in
heart failure. Very long half-life; numerous drug interactions
procainamide - CP
BBW: Potentially fatal blood dyscrasias (agranulocytosis). Long term use leads to positive antinuclear antibody
(ANA) in 50% of patients, which can result in drug-induced lupus erythematosus (DILE) in 20-30% of patients
lidocaine
Indication(s): Ventricular arrhythmias (refractory VT/ cardiac arrest)
adenosine - CP
Indications: Supraventricular re-entrant tachycardias
Notes: Half-life < 10 seconds
atropine - CP
Indications: bradycardia, inhibition of salivation and secretions, organophosphate poisoning